TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 52 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $209,100 | +2.0% | 11,767 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $205,076 | +83.9% | 11,349 | +27.9% | 0.00% | 0.0% |
| Q1 2023 | $111,496 | -12.5% | 8,870 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $127,439 | -14.5% | 8,693 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $149,000 | +20.2% | 8,725 | +2.8% | 0.00% | 0.0% |
| Q2 2022 | $124,000 | +77.1% | 8,486 | +102.7% | 0.00% | – |
| Q1 2022 | $70,000 | -30.7% | 4,186 | -6.6% | 0.00% | -100.0% |
| Q4 2021 | $101,000 | +2.0% | 4,480 | -2.9% | 0.00% | 0.0% |
| Q3 2021 | $99,000 | -27.7% | 4,614 | -2.3% | 0.00% | – |
| Q2 2021 | $137,000 | +17.1% | 4,724 | +30.3% | 0.00% | – |
| Q1 2021 | $117,000 | -20.9% | 3,626 | +1.5% | 0.00% | -100.0% |
| Q4 2020 | $148,000 | – | 3,574 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 1,779,158 | $32,149,385 | 4.73% |
| COWEN AND COMPANY, LLC | 1,999,383 | $36,128,850 | 3.00% |
| Vivo Capital, LLC | 2,262,200 | $40,877,954 | 2.82% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $32,300,613 | 1.93% |
| Cormorant Asset Management, LP | 1,421,422 | $25,685,096 | 1.44% |
| Sands Capital Ventures, LLC | 260,000 | $4,698,200 | 1.39% |
| Ghost Tree Capital, LLC | 150,000 | $2,710,500 | 0.90% |
| RTW INVESTMENTS, LP | 2,548,125 | $46,044,619 | 0.88% |
| Perceptive Advisors | 1,296,416 | $23,426,237 | 0.68% |
| TFG Asset Management GP Ltd | 165,000 | $2,981,550 | 0.40% |